Keros Therapeutics Announces Final Results of Tender Offer
Keros Therapeutics Announces Final Results of Tender Offer GlobeNewswire November 20, 2025 LEXINGTON, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), today announced the final results of its cash tender offer (the “Tender Offer”) to repurchase up to 10,950,165 shares of its common stock, at a fixed […]